BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 33168076)

  • 1. Mycophenolic acid, the active form of mycophenolate mofetil, interferes with IRF7 nuclear translocation and type I IFN production by plasmacytoid dendritic cells.
    Shigesaka M; Ito T; Inaba M; Imai K; Yamanaka H; Azuma Y; Tanaka A; Amuro H; Nishizawa T; Son Y; Satake A; Ozaki Y; Nomura S
    Arthritis Res Ther; 2020 Nov; 22(1):264. PubMed ID: 33168076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitor of IkappaB kinase activity, BAY 11-7082, interferes with interferon regulatory factor 7 nuclear translocation and type I interferon production by plasmacytoid dendritic cells.
    Miyamoto R; Ito T; Nomura S; Amakawa R; Amuro H; Katashiba Y; Ogata M; Murakami N; Shimamoto K; Yamazaki C; Hoshino K; Kaisho T; Fukuhara S
    Arthritis Res Ther; 2010; 12(3):R87. PubMed ID: 20470398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysfunctional interferon-alpha production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus.
    Kwok SK; Lee JY; Park SH; Cho ML; Min SY; Park SH; Kim HY; Cho YG
    Arthritis Res Ther; 2008; 10(2):R29. PubMed ID: 18321389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
    Sakata K; Nakayamada S; Miyazaki Y; Kubo S; Ishii A; Nakano K; Tanaka Y
    Front Immunol; 2018; 9():1957. PubMed ID: 30210502
    [No Abstract]   [Full Text] [Related]  

  • 5. Activated T cells enhance interferon-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes.
    Leonard D; Eloranta ML; Hagberg N; Berggren O; Tandre K; Alm G; Rönnblom L
    Ann Rheum Dis; 2016 Sep; 75(9):1728-34. PubMed ID: 26493814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Sacre K; Criswell LA; McCune JM
    Arthritis Res Ther; 2012 Jun; 14(3):R155. PubMed ID: 22734582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgE Inhibits Toll-like Receptor 7- and Toll-like Receptor 9-Mediated Expression of Interferon-α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
    Khoryati L; Augusto JF; Shipley E; Contin-Bordes C; Douchet I; Mitrovic S; Truchetet ME; Lazaro E; Duffau P; Couzi L; Jacquemin C; Barnetche T; Vacher P; Schaeverbeke T; Blanco P; Richez C;
    Arthritis Rheumatol; 2016 Sep; 68(9):2221-31. PubMed ID: 26991804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus.
    Murayama G; Furusawa N; Chiba A; Yamaji K; Tamura N; Miyake S
    Arthritis Res Ther; 2017 Oct; 19(1):234. PubMed ID: 29052537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities in circulating plasmacytoid dendritic cells in patients with systemic lupus erythematosus.
    Jin O; Kavikondala S; Mok MY; Sun L; Gu J; Fu R; Chan A; Yeung J; Nie Y; Lau CS
    Arthritis Res Ther; 2010; 12(4):R137. PubMed ID: 20618924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG-C immunostimulatory oligodeoxyribonucleotide activation of plasmacytoid dendritic cells in rhesus macaques to augment the activation of IFN-gamma-secreting simian immunodeficiency virus-specific T cells.
    Teleshova N; Kenney J; Jones J; Marshall J; Van Nest G; Dufour J; Bohm R; Lifson JD; Gettie A; Pope M
    J Immunol; 2004 Aug; 173(3):1647-57. PubMed ID: 15265893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heightened TLR7/9-Induced IL-10 and CXCL13 Production with Dysregulated NF-ҝB Activation in CD11c
    Yim LY; Lau CS; Chan VS
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phthalates suppress type I interferon in human plasmacytoid dendritic cells via epigenetic regulation.
    Kuo CH; Hsieh CC; Kuo HF; Huang MY; Yang SN; Chen LC; Huang SK; Hung CH
    Allergy; 2013 Jul; 68(7):870-9. PubMed ID: 23738920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
    Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
    Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of interferon regulatory factor 7 in plasmacytoid dendritic cells promotes experimental autoimmune pancreatitis.
    Minaga K; Watanabe T; Arai Y; Shiokawa M; Hara A; Yoshikawa T; Kamata K; Yamashita K; Kudo M
    J Gastroenterol; 2020 May; 55(5):565-576. PubMed ID: 31960143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis.
    Dieker J; Tel J; Pieterse E; Thielen A; Rother N; Bakker M; Fransen J; Dijkman HB; Berden JH; de Vries JM; Hilbrands LB; van der Vlag J
    Arthritis Rheumatol; 2016 Feb; 68(2):462-72. PubMed ID: 26360137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, function as inhibitors of cellular and molecular components involved in type I interferon production.
    Amuro H; Ito T; Miyamoto R; Sugimoto H; Torii Y; Son Y; Nakamichi N; Yamazaki C; Hoshino K; Kaisho T; Ozaki Y; Inaba M; Amakawa R; Fukuhara S
    Arthritis Rheum; 2010 Jul; 62(7):2073-85. PubMed ID: 20506142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression.
    Jin O; Kavikondala S; Sun L; Fu R; Mok MY; Chan A; Yeung J; Lau CS
    Lupus; 2008 Jul; 17(7):654-62. PubMed ID: 18625638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells.
    Sköld AE; Mathan TSM; van Beek JJP; Flórez-Grau G; van den Beukel MD; Sittig SP; Wimmers F; Bakdash G; Schreibelt G; de Vries IJM
    Cancer Immunol Immunother; 2018 Sep; 67(9):1425-1436. PubMed ID: 30019146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
    Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK
    Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
    Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
    Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.